Purchase Order 75N90021P00498

This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), an institute of the National Institutes of Health (NIH), to Stemcell Technologies Inc. for $99,528 to supply 160 EasySep Negative Human CD4 Kits. The solicitation specified this as a brand name requirement to support NIAID's Laboratory of Immunoregulation's ongoing clinical trials and research into understanding how the host immune system controls HIV viral replication without...

The National Institute of Allergy and Infectious Diseases (NIAID), a sub-agency of the U.S. Department of Health and Human Services (HHS), awarded a $80,536.00 firm-fixed-price purchase order contract to Stemcell Technologies Inc. for EasySep Negative Human CD4 and CD8 Kits. This contract does not have a set-aside designation. Stemcell Technologies Inc. is a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $3,850.00 firm fixed-price purchase order to Stemcell Technologies Inc., a foreign-owned for-profit organization, for the delivery of an EasySep Human Naive CD4+ T Cell Isolation Kit II. This small business set-aside contract provides specialized biological research materials to facilitate studies related to infectious diseases, immunology, and other areas...

This contract was awarded by the Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases to Stemcell Technologies Inc., a foreign-owned for-profit organization, to provide EasySep Negative Human CD4 Kits and EasySep Negative Human CD8 Kits. The total potential value of the award is $99,317.40. This was a sole-source procurement made under the authority of FAR 13.106-1, as the agency determined Stemcell Technologies Inc. was...

This federal contract award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the Department of Health and Human Services (HHS), to Stemcell Technologies Inc., a Canadian biotechnology company. The $6,699 firm fixed-price contract is for the delivery of EasySep Negative Human CD4 Kits, which are specialized cell isolation products used to support biomedical research, particularly in areas like immunology and infectious disease investigations....

This is a $17,134.00 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Stemcell Technologies Inc., a Canadian biotechnology company. The contract is for the supply of EasySep Negative Human CD4 Kits, which are used in cell separation and cell culture applications to support biomedical research. The contract is a Blanket Purchase Agreement (BPA) call, meaning it is part of a larger indefinite...

This is a federal contract award to Stemcell Technologies Inc., a Canadian biotechnology company, for the supply of an EasySep Negative Human CD4 Kit, catalog number 19052. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) within the U.S. Department of Health and Human Services (HHS). The contract has a ceiling value of $39,906.40 and is structured as a firm fixed price purchase order. The contract is...

The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases awarded a $17,450.00 Firm Fixed Price purchase order contract to Stemcell Technologies Inc., a Canadian-owned for-profit organization, for the delivery of HUMAN CD8 KITS. The contract has a completion date of June 22, 2018 and does not have a set-aside designation. Stemcell Technologies Inc. is an active supplier of specialized biological materials, laboratory...

The Defense Logistics Agency Troop Support Medical awarded a $64,740 delivery order to Fisher Scientific Company L.L.C. for isolation of Streptococcus pyogenes (Group A) agar. As the prime contractor, Fisher Scientific will provide one hundred counts of STREP A ISOLATION AGAR in accordance with the terms of the delivery order. Performance will occur at Fisher Scientific's facility located in Pittsburgh, Pennsylvania, between August 15-22, 2023. Pricing is set at a fixed rate with economic...

This federal contract award was made by the National Institutes of Health (NIH) to Stemcell Technologies Inc., a Canadian biotechnology company that specializes in cell culture media, cell separation systems, and other life sciences research products. The contract, which is a Blanket Purchase Agreement (BPA) with a ceiling value of $10,000,000, authorizes Stemcell Technologies Inc. to provide a comprehensive range of biological materials, blood and blood products, laboratory supplies, media, and...